85 related articles for article (PubMed ID: 1687823)
1. Behavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's disease.
Horellou P; Lundberg C; Le Bourdellès B; Wictorin K; Brundin P; Kalén P; Björklund A; Mallet J
J Physiol (Paris); 1991; 85(3):158-70. PubMed ID: 1687823
[TBL] [Abstract][Full Text] [Related]
2. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
3. [The changes of striatal dopamine levels in the brain in rat models for Parkinson's disease after gene therapy].
Tong H; Zhang J; Xu Q
Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):490-2. PubMed ID: 9275495
[TBL] [Abstract][Full Text] [Related]
4. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
[TBL] [Abstract][Full Text] [Related]
5. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
6. In vivo L-DOPA production by genetically modified primary rat fibroblast or 9L gliosarcoma cell grafts via coexpression of GTPcyclohydrolase I with tyrosine hydroxylase.
Leff SE; Rendahl KG; Spratt SK; Kang UJ; Mandel RJ
Exp Neurol; 1998 Jun; 151(2):249-64. PubMed ID: 9628761
[TBL] [Abstract][Full Text] [Related]
7. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model.
Lundberg C; Horellou P; Mallet J; Björklund A
Exp Neurol; 1996 May; 139(1):39-53. PubMed ID: 8635567
[TBL] [Abstract][Full Text] [Related]
8. In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum.
Horellou P; Brundin P; Kalén P; Mallet J; Björklund A
Neuron; 1990 Oct; 5(4):393-402. PubMed ID: 2119630
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Lane EL; Brundin P; Cenci MA
Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
[TBL] [Abstract][Full Text] [Related]
10. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
Jensen P; Pedersen EG; Zimmer J; Widmer HR; Meyer M
Brain Res; 2008 Jul; 1218():13-20. PubMed ID: 18513704
[TBL] [Abstract][Full Text] [Related]
11. Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons.
Rodriguez-Pallares J; Parga JA; Rey P; Guerra MJ; Labandeira-Garcia JL
Synapse; 2005 Oct; 58(1):13-22. PubMed ID: 16037947
[TBL] [Abstract][Full Text] [Related]
12. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
13. Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson's disease.
Ogura T; Ogata M; Akita H; Jitsuki S; Akiba L; Noda K; Hoka S; Saji M
Neurosci Res; 2005 Mar; 51(3):299-308. PubMed ID: 15710494
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapeutic effects on parkinsonian rats of intrastriatal co-grafts with genetically engineered fibroblasts expressing tyrosine hydroxylase and glial cell line-derived neurotrophic factor.
Jingzhong Z; Hui Y; Deyi D; Chunli D; Chunli Z; Xiaohong S; Jinlu Z; Qunyuan X
Int J Neurosci; 2005 Jun; 115(6):769-79. PubMed ID: 16019573
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
[TBL] [Abstract][Full Text] [Related]
16. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 2005 May; 144(1):35-45. PubMed ID: 15848237
[TBL] [Abstract][Full Text] [Related]
17. Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.
Goren B; Kahveci N; Eyigor O; Alkan T; Korfali E; Ozluk K
Surg Neurol; 2005; 64 Suppl 2():S33-41. PubMed ID: 16256839
[TBL] [Abstract][Full Text] [Related]
18. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
19. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
20. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
